SPY328.74-0.05 -0.02%
DIA266.70-0.02 -0.01%
IXIC10,918.10+15.30 0.14%

Needham Initiates Coverage On Phathom Pharmaceuticals with Buy Rating, Announces $40 Price Target

Needham initiates coverage on Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy rating and a $40 price target.

Benzinga · -

Needham initiates coverage on Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy rating and a $40 price target.